Globus Medical (GMED) Tops Q2 EPS by 7c, provides guidance

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.75, $0.07 better than the analyst estimate of $0.68. Revenue for the quarter came in at $629.7 million versus the consensus estimate of $615.33 million.

GUIDANCE:

Globus Medical sees FY 2025 EPS of $2.80-$2.90, versus the consensus of $2.82. Globus Medical sees FY 2025 revenue of $2.47-2.49 billion, versus the consensus of $2.475 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Blackstone to invest $30B in AI data centers in Japan over the next 3 to 5 years, says president and COO Jonathan Gray - Nikkei
• EG Group confidentially filed for $1 billion U.S. IPO - Bloomberg